Recall Radar · 美国食品召回雷达

← Search recalls / 搜索召回公告

FDA Recalls, Market Withdrawals & Safety Alerts · Other / 其他

4.2% Sodium Bicarbonate Injection, USP, 1% Lidocaine HCl Injection, USP, and 2% Lidocaine HCl Injection, USP

Recall fda-alert:2023-10-02:Hospira:4.2% Sodium Bicarbonate Injection, USP, 1% Lidocaine HCl Injection, USP, and 2% Lidocaine HCl Injection, USP · Published 2023-10-02

Official-information notice / 官方信息说明: This page transcribes fields from the named agency record. It is not medical, legal, or food-safety advice. Follow the agency's original notice and instructions.

Recall number / 召回编号

fda-alert:2023-10-02:Hospira:4.2% Sodium Bicarbonate Injection, USP, 1% Lidocaine HCl Injection, USP, and 2% Lidocaine HCl Injection, USP

Classification / 风险等级

Other / 其他

Published / 发布时间

2023-10-02

Recalling firm / 召回企业

Hospira, Inc.

Product description / 产品描述

4.2% Sodium Bicarbonate Injection, USP, 1% Lidocaine HCl Injection, USP, and 2% Lidocaine HCl Injection, USP

Product code / 产品代码

Not provided in the official record

Code information / 批次与代码信息

Not provided in the official record

Product quantity / 产品数量

Not provided in the official record

Distribution / 销售地区

Not provided in the official record

Reason for recall / 召回原因

Potential Presence of Glass Particulates

Open official source ↗ / 打开官方来源

Last synchronized: 2023-10-02. Recall Radar does not replace agency guidance.